2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-, hydrochloride, hydrate (1:1:1)

CAS: 138982-67-9

Ref. AN-AG0019YR

Información del producto

• Nombre: 2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-, hydrochloride, hydrate (1:1:1)
• Sinónimos: [u'5-(2-(4-(3-benzisothiazolyl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one', u'CP 88059', u'CP 88059-01', u'CP-88,059', u'CP-88,059-01', u'CP-88,059-1', u'Geodon', u'ziprasidone', u'ziprasidone hydrochloride', u'ziprasidone hydrochloride, monohydrate', u'ziprazidone', u'138982-67-9', u'Ziprasidone hydrochloride monohydrate', u'Ziprasidone hydrochloride', u'Geodon', u'5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one hydrochloride hydrate', u'Ziprasidone HCl hydrate', u'UNII-216X081ORU', u'MFCD00921885', u'Ziprasidone hydrochloride [USAN:USP]', u'Ziprasidone (hydrochloride monohydrate)', u'CP-88059', u'CP 88,059-1', u'216X081ORU', u'Zeldox', u'Ziprasidone hydrochloride [USAN]', u'Geodon (TN)', u'ZIPRASIDONE HYDROCHLORIDE HYDRATE', u'5-(2-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-2-indolinone monohydrochloride, monohydrate', u'C21H21ClN4OS.HCl', u'CHEBI:32314', u'Ziprasidone hydrochloride (USAN)', u'2H-Indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-, monohydrochloride, monohydrate', u'5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride monohydrate', u'NCGC00186050-01', u'CP 88059', u'CP-880591', u'CP 88059-1', u'CP-88,059-1', u'zlchem 4', u'5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;hydrate;hydrochloride', u'AC1Q3ESV', u'Ziprasidone HCl monohydrate', u'Geodon Hydrochloride Hydrate', u'SCHEMBL122875', u'AC1L1U24', u'CHEMBL1375743', u'CTK8B7827', u'C21H21ClN4OS.HCl[H2O]', u'DTXSID00160855', u'SYN3019', u'ZLA0004', u'ZCBZSCBNOOIHFP-UHFFFAOYSA-N', u'Tox21_501025', u'ANW-58715', u'CZ0015', u'GP6084', u'ziprasidone hydrochloride, monohydrate', u'AKOS015961662', u'AN-9382', u'API0004648', u'CCG-222329', u'CS-1198', u'LP01025', u'ME-2112', u'RTR-031719', u'TRA0084802', u'Ziprasidone hydrochloride hydrate (JAN)', u'NCGC00261710-01', u'AK-75766', u'AS-16359', u'BC207663', u'HY-17407', u'LS-173039', u'TR-031719', u'4CH-021473', u'FT-0600387', u'ST24044165', u'CP-88059-01', u'CP 88-059-01', u'D01939', u'982Z679', u'C-35605', u'J-007206', u'Ziprasidone hydrochloride monohydrate, >=98% (HPLC), solid', u'Ziprasidone for system suitability 1, European Pharmacopoeia (EP) Reference Standard', u'Ziprasidone for system suitability 2, European Pharmacopoeia (EP) Reference Standard', u'Ziprasidone Hydrochloride Monohydrate 1.0 mg/ml in Methanol (as anhydrous free base)', u'Ziprasidone hydrochloride monohydrate, European Pharmacopoeia (EP) Reference Standard', u'Ziprasidone hydrochloride, United States Pharmacopeia (USP) Reference Standard', u'2H-Indol-2-one,5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl_ethyl)-6-chloro-1,3-dihydro-monohydrochloride,monohydrate', u'5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one Hydrochloride Monohydrate, CP-88059-1', u'5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one hydrate hydrochloride'], 2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-, monohydrochloride, monohydrate, 5-(2-(4-(1,2-Benzisothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one hydrochloride hydrate, 5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride monohydrate, 5-[2-[4-(1,2-Benzisothiazol-3Yl)-1-Piperazinyl]Ethyl]-6-Chloro-1,3-Dihydro-2H-Indol-2-One Hydrochloride, 5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one, 5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride (1:1), 5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride hydrate, Ziprasidone HCL, Ziprasidone hcl monohydrate, Ziprasidone monohydrochloride monohydrate, Ziprasitone Hcl Monohydrate, Ziprasitone Hydrochloride monohydrate
• CAS: 138982-67-9
• Marca: Indagoo

Propiedades químicas

• Peso molecular: 467.4119
• Fórmula: C₂₁H₂₄Cl₂N₄O₂S
• Pureza: 98%
• Color/Forma: Solid
• InChI: InChI=1S/C21H21ClN4OS.ClH.H2O/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21;;/h1-4,11,13H,5-10,12H2,(H,23,27);1H;1H2
• Clave InChI: ZCBZSCBNOOIHFP-UHFFFAOYSA-N